Clinical Trial Update: DRV/r + RPV QD: Efficacy and Toxicity Reduction [Phase 3]

View source ↗

Summary

Phase 3 trial update on DRV/r combined with RPV once daily showing efficacy and reduced toxicity in HIV treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DRV/r + RPV QD

Snippet

Sponsor: ASST Fatebenefratelli Sacco | Conditions: Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED